Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions ...
European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...
The Phase 3 findings position semaglutide to become the first drug of its kind for the liver disease. But they also confirm ...
Allurion Technologies announced today that it submitted three modules for its weight loss balloon to the FDA for premarket ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...
Both Ozempic and Mounjaro are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, but some ...
Ozempic is arguably the buzziest buzzword in our culture today. But we still have plenty of questions about the type 2 ...